EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type IIFN

被引:249
作者
Samanta, Mrinal
Iwakiri, Dai
Kanda, Teru
Imaizumi, Tadaatsu
Takada, Kenzo
机构
[1] Hokkaido Univ, Dept Tumor Virol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido 0600815, Japan
[2] Hirosaki Univ, Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori 036, Japan
关键词
Burkitt's lymphoma; EBER; EBV; RIG-I; type IIFN;
D O I
10.1038/sj.emboj.7601314
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) are nonpolyadenylated, untranslated RNAs, exist most abundantly in latently EBV-infected cells, and are expected to show secondary structures with many short stem loops. Retinoic acid-inducible gene I (RIG-I) is a cytosolic protein that detects viral double-stranded RNA (dsRNA) inside the cell and initiates signaling pathways leading to the induction of protective cellular genes, including type I interferons (IFNs). We investigated whether EBERs were recognized by RIG-I as dsRNA. Transfection of RIG-I plasmid induced IFNs and IFN-stimulated genes (ISGs) in EBV-positive Burkitt's lymphoma (BL) cells, but not in their EBV-negative counterparts or EBER-knockout EBV-infected BL cells. Transfection of EBER plasmid or in vitro-synthesized EBERs induced expression of type I IFNs and ISGs in RIG-I-expressing, EBV-negative BL cells, but not in RIG-I-minus counterparts. EBERs activated RIG-I's substrates, NF-kappa B and IFN regulatory factor 3, which were necessary for type I IFN activation. It was also shown that EBERs co-precipitated with RIG-I. These results indicate that EBERs are recognized by RIG-I and activate signaling to induce type I IFN in EBV-infected cells.
引用
收藏
页码:4207 / 4214
页数:8
相关论文
共 36 条
[1]   2 FAMILIES OF SEQUENCES IN THE SMALL RNA-ENCODING REGION OF EPSTEIN-BARR VIRUS (EBV) CORRELATE WITH EBV TYPE-A AND TYPE-B [J].
ARRAND, JR ;
YOUNG, LS ;
TUGWOOD, JD .
JOURNAL OF VIROLOGY, 1989, 63 (02) :983-986
[2]   BINDING OF EPSTEIN-BARR-VIRUS SMALL RNA EBER-1 TO THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN-KINASE DAI [J].
CLARKE, PA ;
SCHWEMMLE, M ;
SCHICKINGER, J ;
HILSE, K ;
CLEMENS, MJ .
NUCLEIC ACIDS RESEARCH, 1991, 19 (02) :243-248
[3]   Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling [J].
Foy, E ;
Li, K ;
Sumpter, R ;
Loo, YM ;
Johnson, CL ;
Wang, CF ;
Fish, PM ;
Yoneyama, M ;
Fujita, T ;
Lemon, SM ;
Gale, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :2986-2991
[4]   STRUCTURAL-ANALYSES OF EBER1 AND EBER2 RIBONUCLEOPROTEIN-PARTICLES PRESENT IN EPSTEIN-BARR VIRUS-INFECTED CELLS [J].
GLICKMAN, JN ;
HOWE, JG ;
STEITZ, JA .
JOURNAL OF VIROLOGY, 1988, 62 (03) :902-911
[5]   DIFFERENT EPSTEIN-BARR VIRUS-B CELL-INTERACTIONS IN PHENOTYPICALLY DISTINCT CLONES OF A BURKITTS-LYMPHOMA CELL-LINE [J].
GREGORY, CD ;
ROWE, M ;
RICKINSON, AB .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :1481-1495
[6]   EPSTEIN-BARR VIRUS-CODED BHRF1 PROTEIN, A VIRAL HOMOLOG OF BCL-2, PROTECTS HUMAN B-CELLS FROM PROGRAMMED CELL-DEATH [J].
HENDERSON, S ;
HUEN, D ;
ROWE, M ;
DAWSON, C ;
JOHNSON, G ;
RICKINSON, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8479-8483
[7]   INDUCTION OF BCL-2 EXPRESSION BY EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 PROTECTS INFECTED B-CELLS FROM PROGRAMMED CELL-DEATH [J].
HENDERSON, S ;
ROWE, M ;
GREGORY, C ;
CROOMCARTER, D ;
WANG, F ;
LONGNECKER, R ;
KIEFF, E ;
RICKINSON, A .
CELL, 1991, 65 (07) :1107-1115
[8]   Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-γ [J].
Imaizumi, T ;
Yagihashi, N ;
Hatakeyama, M ;
Yamashita, K ;
Ishikawa, A ;
Taima, K ;
Yoshida, H ;
Inoue, I ;
Fukita, T ;
Yagihashi, S ;
Satoh, K .
LIFE SCIENCES, 2004, 75 (10) :1171-1180
[9]   Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines [J].
Iwakiri, D ;
Sheen, TS ;
Chen, JY ;
Huang, DP ;
Takada, K .
ONCOGENE, 2005, 24 (10) :1767-1773
[10]  
Iwakiri D, 2003, CANCER RES, V63, P7062